Harbor Investment Advisory, LLC Ligand Pharmaceuticals Inc Transaction History

Harbor Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	BUY	$94.99 - $151.56 $9,119 - $14,549	96 Added 18.22%	623 $70,000
Q1 2021 Apr 16, 2021	SELL	$99.52 - $215.83 $10,250 - $22,230	-103 Reduced 16.35%	527 $80,000
Q4 2020 Feb 04, 2021	BUY	$80.55 - $106.05 $13,612 - $17,922	169 Added 36.66%	630 $63,000
Q3 2020 Oct 23, 2020	BUY	$89.56 - $126.72 $21,763 - $30,792	243 Added 111.47%	461 $44,000
Q2 2020 Jul 16, 2020	BUY	$68.28 - $123.65 $1,775 - $3,214	26 Added 13.54%	218 $24,000
Q1 2020 May 11, 2020	BUY	$63.37 - $107.88 $12,167 - $20,712	192 New	192 $14,000

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.87B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.